Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2020-05-01
2021-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to determine whether the previous tuberculosis sequelae has a functional effect on patients with COPD.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Role of Tuberculosis in Chronic Obstructive Lung Disease
NCT02759848
Clinical Features of Smoker Patients With Chronic Obstructive Pulmonary Disease
NCT04711629
The Clinical Characteristics, Treatment and Prognosis of Tuberculosis-associated COPD
NCT06074042
Are Comorbidities Related to Frequent Severe Exacerbations of AECOPD
NCT05504993
Research of Burden of Interstititial Lung Diseases in Turkey
NCT03995654
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Within the scope of the evaluation; Demographic and clinical information of the people who will participate in the study will be recorded, and Thorax CT and PFT examinations performed within the polyclinic service within the last 1 month will be evaluated. Saint George Respiratory Questionaire (SGRQ), 6-minute walk test (6MWT), Medical Research Council Dyspnea Scale (MRC), COPD assessment test (CAT) will be applied to the patients. Regarding the illness histories, the number of hospitalizations and emergency admissions in the last 1 year will be recorded. Detailed tuberculosis anamneses will also be taken from patients with tuberculosis sequelae.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
COPD patients with tuberculous sequelae
COPD patients with tuberculous sequelae
Functional Outcome Measurements
Dyspnea Exercise capacity Quality of life assessment
COPD patients without tuberculosis sequela
COPD patients with tuberculous sequelae
Functional Outcome Measurements
Dyspnea Exercise capacity Quality of life assessment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Functional Outcome Measurements
Dyspnea Exercise capacity Quality of life assessment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being over 18 years old
* Having thorax CT in the last 1 month
* Having PFT examination performed in the last 1 month
Exclusion Criteria
* The patient has additional pulmonary comorbidity such as Lung Ca, bronchiectasis, lung fibrosis.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Izmir Katip Celebi University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ilknur Naz
Assoc. Prof
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hulya Sahin
Role: PRINCIPAL_INVESTIGATOR
Izmir Dr. Suat Seren Chest Diseases and Surgery Training and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
İlknur Naz Gürşan
Izmir, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IKC145
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.